Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
DeepIntent ponies up ad guarantees to take the edge off pharmas' programmatic ad hesitation
4 years ago
Marketing
As BioNTech predicts a drop in its mother lode of Covid sales, execs hint at coming M&A deals
4 years ago
Illumina forced to pay almost $334M as it loses DNA sequencing patent case
4 years ago
Law
Psoriasis and psoriatic arthritis drugs crisscross categories, but derm and rheum docs split on preferences
4 years ago
Marketing
Ex-Sanofi CEO on board, a new $158M SPAC debuts looking to shake up the European CDMO market
4 years ago
Manufacturing
Sweeping reorg at Orion — centered around cancer and pain — claims 30 staffers
4 years ago
People
J&J ends hepatitis B and HPV portions of Bavarian Nordic collab
4 years ago
Deals
French regulators refer institute run by outspoken hydroxy advocate for criminal charges
4 years ago
Law
Consortium to automate cell therapy manufacturing welcomes Thermo Fisher and Charles River Labs
4 years ago
Manufacturing
J&J new social media series supports and celebrates ‘warrior’ nurses in pulmonary hypertension
4 years ago
Marketing
Defying biotech bears, Sanofi manufacturing spinoff surges on Paris debut
4 years ago
Financing
BeiGene CEO John Oyler steps up to the Big Pharma league with $16M in comp as shares sour
4 years ago
Financing
After last month's adcomm death knell on its ALS drug, Amylyx looks to post-hoc for saving grace
4 years ago
R&D
Big Pharma is rich. So much so, their coffers could buy more than 600 biotechs
4 years ago
Financing
Deals
PBMs in the Senate hot seat as bipartisan transparency measures may take root
4 years ago
Two Novartis sites stop manufacturing cancer therapies after quality issues
4 years ago
Manufacturing
AstraZeneca's Ultomiris hits primary endpoint for PhIII NMOSD study
4 years ago
R&D
Are pharma marketers finally moving away from traditional TV advertising? Yes, but it’s a slow roll
4 years ago
Marketing
In wake of Biogen's skirmish with the SEC, pharma giants are changing the way they do quarterly reports
4 years ago
J&J sues company over alleged abuse of its cost assistance program
4 years ago
Law
FDA to create training program to inspect more mRNA vaccine manufacturing
4 years ago
Manufacturing
Sanofi reorganizes philanthropy effort, debuts Foundation S 'think and do tank'
4 years ago
Marketing
Societal nabs sole supplier role for Ritalin to Europe
4 years ago
Manufacturing
Shrinking BridgeBio confirms layoffs, details out-licensing plans for its ‘restructuring initiative’
4 years ago
First page
Previous page
202
203
204
205
206
207
208
Next page
Last page